Wiskott-Aldrich syndrome
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Wiskott-Aldrich syndrome Classification and external resources | |
| ICD-10 | D82.0 |
|---|---|
| ICD-9 | 279.12 |
| OMIM | 301000 |
| DiseasesDB | 14176 |
| eMedicine | med/1162 ped/2443 derm/702 |
| MeSH | D014923 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Phone:617-525-7431
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Wiskott-Aldrich syndrome (WAS) is a rare X-linked recessive disease characterized by eczema, thrombocytopenia (low platelet counts), immune deficiency, and bloody diarrhea (due to the low platelet counts). It is also sometimes called the eczema-thrombocytopenia-immunodeficiency syndrome in keeping with Aldrich's original description in 1954.[1]
Signs and symptoms
WAS generally becomes symptomatic in children. Due to its mode of inheritance, the overwhelming majority are male. It is characterised by bruising caused by thrombocytopenia (low platelet counts), small platelet size on blood film, eczema, recurrent infections, and a propensity for autoimmune disorders and malignancies (mainly lymphoma and leukemia).
In Wiskott-Aldrich syndrome, the platelets are small and do not function properly. They are removed by the spleen, which leads to low platelet counts. Splenomegaly is not an uncommon finding. Also, patients develop a type of itchy rash called eczema. Autoimmune disorders are also found in patients with WAS.
Diagnosis
The diagnosis is made on the basis of clinical parameters, the blood film and low immunoglobulin levels. Typically, immunoglobulin M (IgM) levels are low and IgA and IgE levels are elevated; paraproteins are occasionally observed.[1] Skin immunologic testing (allergy testing) may reveal hyposensitivity. It must be remembered that not all patients will have a family history, since they may be the first to harbor the gene mutation. Often, leukemia may initially be suspected on the basis of the low platelets and the infections, and bone marrow biopsy may be performed. Decreased levels of Wiskott-Aldrich syndrome protein and/or confirmation of a causative mutation provides the most definitive diagnosis.
Classification
Jin et al (2004) employ a numerical grading of severity:[1]
- 0.5: intermittent thrombopenia
- 1.0: thrombopenia and small platelets
- 2.0: thrombopenia and normally responsive eczema or occasional upper respiratory tract infections.
- 2.5: thrombopenia and therapy-responsive but severe eczema or airway infections requiring antibiotics
- 3.0: both eczema and airway infections requiring antibiotics
- 4.0: eczema continuously requiring therapy and/or severe or life threatening infections
- 5.0: autoimmune disease or malignancy in an XLT/WAS patient.
Pathophysiology
Wiskott-Aldrich syndrome was linked in 1994 to mutations in a gene on the short arm of the X chromosome, which was termed Wiskott-Aldrich syndrome protein (WASP). It was later discovered that the disease X-linked thrombocytopenia (XLT) was also due to WASP mutations, but different ones from those that cause full-blown Wiskott-Aldrich syndrome. Furthermore, the rare disorder X-linked neutropenia has been linked to particular mutations of the WASP gene.
The WASP gene codes for the protein by the same name, which is 502 amino acids long and is mainly expressed in hematopoietic cells (the cells in the bone marrow that develop into blood cells). Its exact function is being investigated, but signal transduction and cytoskeleton maintenance have been suggested.
The immune deficiency is caused by decreased antibody production, although T cells are also affected (making it a combined immunodeficiency). This leads to increased susceptibility to infections, particularly of the ears and sinuses.
The type of mutation to the WASP gene correlates significantly with the degree of severity: those that led to the production of a truncated protein caused significantly more symptoms than those with a missense mutation but a normal-length WASP.[1] Although autoimmune disease and malignancy occur in both types of mutation, those patients with truncated WASP carry a higher risk.
Epidemiology
The combined incidence of WAS and XLT is about 4-10 in 1 million live births. There is no geographical factor.
Treatment
Treatment of Wiskott-Aldrich syndrome is based on correcting symptoms. Aspirin and other non-steroidal anti-inflammatory drugs should be avoided, since these may interfere with platelet function. A protective helmet can protect children from bleeding into the brain which could result from head injuries. For severely low platelet counts, patients may require platelet transfusions or a splenectomy. For patients with frequent infections, intravenous immunoglobulins (IVIG) can be given to boost the immune system. Anemia from bleeding may require iron supplementation or blood transfusion.
As Wiskott-Aldrich syndrome is primarily a disorder of the blood-forming tissues, a hematopoietic stem cell transplant, accomplished through a cord blood or bone marrow transplant offers the only hope of cure. This treatment is inherently fraught with risks, but is nonetheless recommended for patients with HLA-identical donors, matched sibling donors, or even in cases of incomplete matches if the patient is age 5 or under.
History
The syndrome is named after Dr Robert Anderson Aldrich, an American pediatrician who described the disease in a family of Dutch-Americans in 1954,[1] and Dr Alfred Wiskott, a German pediatrician who first noticed the syndrome in 1937.[1] Wiskott described three brothers with a similar disease, whose sisters were unaffected. In 2006 a German research group analysed family members of Wiskott's three cases, and surmised that they probably shared a novel frameshift mutation of the first exon of the WAS gene.[1]
References
External links
- Immune Deficiency Foundation - Chapter VII, "The Wiskott-Aldrich Syndrome"
WikiDoc Research Resources for Wiskott-Aldrich syndrome (Click show to right to view) | |
|---|---|
| Articles on Wiskott-Aldrich syndrome | Most recent articles on Wiskott-Aldrich syndrome • Most cited articles on Wiskott-Aldrich syndrome • Review articles on Wiskott-Aldrich syndrome • Articles on Wiskott-Aldrich syndrome in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Wiskott-Aldrich syndrome | Powerpoint slides on Wiskott-Aldrich syndrome • Images of Wiskott-Aldrich syndrome • Photos of Wiskott-Aldrich syndrome • Podcasts & MP3s on Wiskott-Aldrich syndrome • Videos on Wiskott-Aldrich syndrome |
| Evidence Based Medicine Regarding Wiskott-Aldrich syndrome | Cochrane Collaboration on Wiskott-Aldrich syndrome • Bandolier on Wiskott-Aldrich syndrome • TRIP on Wiskott-Aldrich syndrome |
| Cost Effectiveness of Wiskott-Aldrich syndrome | Cost Effectiveness of Wiskott-Aldrich syndrome |
| Clinical Trials Involving Wiskott-Aldrich syndrome | Ongoing Trials on Wiskott-Aldrich syndrome at Clinical Trials.gov • Trial results on Wiskott-Aldrich syndrome • Clinical Trials on Wiskott-Aldrich syndrome at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Wiskott-Aldrich syndrome | US National Guidelines Clearinghouse on Wiskott-Aldrich syndrome • NICE Guidance on Wiskott-Aldrich syndrome • NHS PRODIGY Guidance • FDA on Wiskott-Aldrich syndrome • CDC on Wiskott-Aldrich syndrome |
| Textbook Information on Wiskott-Aldrich syndrome | Books and Textbook Information on Wiskott-Aldrich syndrome |
| Pharmacology Resources on Wiskott-Aldrich syndrome | Dosing of Wiskott-Aldrich syndrome • Drug interactions with Wiskott-Aldrich syndrome • Side effects of Wiskott-Aldrich syndrome • Allergic reactions to Wiskott-Aldrich syndrome • Overdose information on Wiskott-Aldrich syndrome • Carcinogenicity information on Wiskott-Aldrich syndrome • Wiskott-Aldrich syndrome in pregnancy • Pharmacokinetics of Wiskott-Aldrich syndrome • |
| Genetics, Pharmacogenomics, and Proteinomics of Wiskott-Aldrich syndrome | Genetics of Wiskott-Aldrich syndrome • Pharmacogenomics of Wiskott-Aldrich syndrome • Proteomics of Wiskott-Aldrich syndrome |
| Newstories on Wiskott-Aldrich syndrome | Wiskott-Aldrich syndrome in the news • Be alerted to news on Wiskott-Aldrich syndrome • News trends on Wiskott-Aldrich syndrome |
| Commentary on Wiskott-Aldrich syndrome | Blogs on Wiskott-Aldrich syndrome |
| Patient Resources on Wiskott-Aldrich syndrome | Patient resources on Wiskott-Aldrich syndrome • Discussion groups on Wiskott-Aldrich syndrome • Patient Handouts on Wiskott-Aldrich syndrome • Directions to Hospitals Treating Wiskott-Aldrich syndrome • Risk calculators and risk factors for Wiskott-Aldrich syndrome |
| Healthcare Provider Resources on Wiskott-Aldrich syndrome | Symptoms of Wiskott-Aldrich syndrome • Causes & Risk Factors for Wiskott-Aldrich syndrome • Diagnostic studies for Wiskott-Aldrich syndrome • Treatment of Wiskott-Aldrich syndrome |
| Continuing Medical Education (CME) Programs on Wiskott-Aldrich syndrome | CME Programs on Wiskott-Aldrich syndrome |
| International Resources on Wiskott-Aldrich syndrome | Wiskott-Aldrich syndrome en Espanol • Wiskott-Aldrich syndrome en Francais |
| Business Resources on Wiskott-Aldrich syndrome | Wiskott-Aldrich syndrome in the Marketplace • Patents on Wiskott-Aldrich syndrome |
| Informatics Resources on Wiskott-Aldrich syndrome | List of terms related to Wiskott-Aldrich syndrome |
fr:Syndrome de Wiskott-Aldrich
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
